Myla Health offers menopause appointments online and at UK clinic locations, with a stated aim of working alongside a patient’s NHS GP. Its useful distinction is between prescribing privately itself and asking another clinician to take over. The second outcome is not guaranteed by the first appointment.
This review reads Myla’s official homepage, pricing page and FAQ as retrieved September 28, 2026. It describes a UK clinical service, not a route to estrogen delivery in the United States. We have not booked care, obtained a pharmacy quote or tested how an NHS practice responds to a Myla recommendation.
A private consultation can lead to a treatment recommendation, but NHS prescribing and the pharmacy charge remain separate questions.
The location rule applies to online appointments too
The homepage describes menopause care through online appointments and clinics in several UK areas. The FAQ supplies the decisive access rule: patients must be on UK soil during the appointment, and medication delivery requires a UK address. An online consultation is therefore not an invitation to receive care from any country.
Check the location and appointment format for the selected clinician before payment. The Newson Clinic review provides another UK private-care comparison. For contrast, Alpha Hormones publishes a limited US-state scope. These geographical records should stay visible in a directory so that a familiar hormone name does not obscure where the actual clinical service operates.
The first appointment and the review have separate prices
Myla’s pricing page lists a forty-five-minute initial consultation at £290 and a thirty-minute follow-up at £190, with the displayed prices effective from April 1, 2026. It describes a review around three months after starting hormonal treatment as its usual service pathway, rather than including that later appointment within the initial fee.
The page also offers installment payment using a stated £96.70 monthly figure over three months. We do not turn that into a general subscription or infer additional finance terms. Confirm the complete payment arrangement directly. The FAQ says payment is normally taken at booking, making appointment selection and cancellation conditions relevant before a clinical consultation has occurred.
Private prescribing and NHS continuation are different decisions
The FAQ says Myla can issue private prescriptions through Pharmacierge, which arranges delivery. It also explains that the clinic can write to an NHS GP with recommendations, but cannot itself issue NHS prescriptions. Local formularies and prescribing policies matter, and the GP is not obliged to accept a requested prescription.
That qualification narrows the pricing page’s broader statement that most medication can be obtained through the NHS. Ask who will prescribe after the initial period and what happens if the GP declines. Our questions-before-starting guide helps organize continuity questions. A private consultation letter can support communication, but it should not be treated as a promise of NHS access or future medication cost.
The prescription fee is separate from the medicine
The pricing page says Myla does not charge for providing private prescriptions during the first three months, while the pharmacy still charges for the actual drug. Subsequent private prescriptions incur a £35 administration charge. The FAQ describes continued clinical review when Myla remains responsible for prescribing.
A no-fee prescription document therefore does not mean free medication. Ask for the pharmacy’s price, quantity and delivery terms for the actual medicine before comparing an overall cost. If the review appointment is delayed or a supply issue arises, the FAQ describes interim prescribing as conditional on the clinician’s judgment and the patient’s circumstances. It is not an automatic refill entitlement or an instruction to change treatment.
Body-identical terminology still needs the exact medicine
Myla’s FAQ says its clinicians use regulated body-identical HRT and do not prescribe compounded bioidentical hormones. Elsewhere in the same FAQ it notes that testosterone use in women can be off-label. Those statements should remain together: a medicine’s licensing status and whether a particular use is licensed are related but different questions.
The NHS HRT overview explains the range of hormones and routes and the separate position of testosterone. Ask for the actual estrogen product and purpose. The local-versus-systemic guide and estrogen-and-progesterone guide can help frame that conversation without selecting a formulation or assuming that every person needs a multi-hormone plan.
Records and messages have limits on clinical responsibility
The FAQ welcomes relevant records but does not guarantee they will be reviewed before the appointment. It distinguishes uploading outside results from a clinician formally reviewing and interpreting them. It also describes email as suitable for clarification and brief questions, with more complex concerns potentially requiring a follow-up appointment.
Those are useful boundaries for a private service. Sending a document is not confirmation that responsibility for its findings has transferred. Ask who is reviewing a concern and how to obtain timely help when routine correspondence is insufficient. We have not tested Myla’s response times. The website’s contact arrangements should not be read as an emergency service or as proof that every clinical issue can be resolved by email.
Booking terms belong beside the care proposal
Myla’s FAQ specifies cancellation charges: the full fee for less than twenty-four hours’ notice and half the fee for more than twenty-four hours but less than two working days. It separately says cancellation or rescheduling more than forty-eight hours beforehand incurs no fee. Because working days and elapsed hours differ, confirm the deadline for the actual appointment, particularly near weekends.
Keep that booking record with the private prescription and possible NHS handover arrangements in the provider comparison. Myla’s published details help define a UK care relationship; they do not establish individual suitability, reimbursement or guaranteed continuity through another clinician. The remaining decision requires an actual assessment and agreement about who provides each part of care.
Sources & reading
Source check dates appear with each record below. Provider pages describe their own services; they do not establish clinical superiority.
- Myla Health: menopause and women’s health clinics ↗UK provider care page · Checked 2026-09-28
- Myla Health: appointment, prescription and access FAQs ↗UK provider care and administrative policy · Checked 2026-09-28
- Myla Health: pricing effective April 1, 2026 ↗UK provider pricing page · Checked 2026-09-28
- NHS: types of hormone replacement therapy ↗UK public health guidance · Checked 2026-09-28